Torigen Pharmaceuticals, a commercial-stage animal health company in Farmington, has closed on a $13 million round of venture capital financing.
Ashley Kalinauskas, CEO and co-founder of Torigen, said the infusion of money will allow the company to continue developing new products to help pets diagnosed with cancer and other immune diseases. “Our goal is to create the industry’s first oncology toolbox for veterinarians,” Kalinauskas said.